top of page

Peggy Wentworth

Peggy_Wentworth_Headshot 2022 (1).jpg

Dr Wentworth has more than 20+ years’ experience in drug development and global clinical research. She has comprehensive expertise in strategic and tactical development of biologics and small molecule drugs through all stages of development, an extensive background in development of Oncology therapeutics, a capability of overseeing and coordinating all aspects of drug development within different functional areas and extensive experience in management of complex, global programs. Dr. Wentworth is highly experienced in program management and brings substantial experience in leading cross-functional development teams as well as functioning as a drug development advisor for grants (CIRM, STTR, SBIR grants).  She also has experience managing CMC and Nonclinical activities for academic projects (above mentioned CIRM grants) and pharmaceutical companies. She has contributed to numerous INDs (small molecule, biologic, antisense drugs) and participated in a number of FDA meetings. Dr. Wentworth has a PhD from Emory University in Immunology and Microbiology.

bottom of page